Cozzani, V.; Barontini, F.; McGrath, T.; Mahler, B.; Nordlund, M.; Smith, M.; Schaller, J. P.; Zuber, G.
An experimental investigation of the thermal processes taking place in the tobacco substrate of a recently developed multicomponent electrically heated tobacco product (EHTP) that is part of an electrically heated tobacco system (EHTS – also referred to as the Tobacco Heating System 2.2) was carried out. Temperature profiles in the tobacco substrate of the EHTP were characterized using thermocouples positioned at different distances from the heater surface. The average maximum temperature of the tobacco measured 0.2 mm from the heater’s surface was < 260 °C, well below the temperature required for the self-sustaining smoldering combustion of the tobacco substrate to occur. The chemical composition of the aerosol generated from the EHTP when the EHTS was operated under oxidative and non-oxidative atmospheres was investigated. The aerosol derived from the controlled heating of the tobacco substrate is comprised principally of water, nicotine and glycerol that are evaporated from the tobacco substrate. No significant change in aerosol composition and in the amounts of CO, NO and NOx were detected when comparing the aerosol formed under non-oxidative (where combustion processes cannot occur) and oxidative atmospheres.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.